We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
-7.91%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$118M
AUM Growth
-$15.7M
Cap. Flow
+$577K
Cap. Flow %
0.49%
Top 10 Hldgs %
75.47%
Holding
54
New
–
Increased
13
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
AXGN icon
Axogen
AXGN
+$921K
2
PRTA icon
Prothena Corp
PRTA
+$800K
3
BLUE
bluebird bio
BLUE
+$723K
4
TVTX icon
Travere Therapeutics
TVTX
+$593K
5
TXG icon
10x Genomics
TXG
+$468K

Top Sells

Rank Stock Value
1
SLNO
Soleno Therapeutics
SLNO
+$1.05M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$984K
3
UTHR icon
United Therapeutics
UTHR
+$921K
4
BMY icon
Bristol-Myers Squibb
BMY
+$753K
5
NBIX icon
Neurocrine Biosciences
NBIX
+$737K

Sector Composition

Rank Sector Weight
1 Healthcare 94.79%
2 Energy 5.2%
3 Consumer Staples 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YTEN
51
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$6.13K 0.01%
781
– –
SLNO
52
DELISTED
Soleno Therapeutics
SLNO
– –
-245,127
Closed -$1.05M
KDNY
53
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-15,000
Closed -$576K
ISEE
54
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-25,000
Closed -$984K
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
FPW
Flywheel Private Wealth Los Altos, California $176M AUM 26.12% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return

Birchview Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Birchview Capital held 54 positions worth $118M, down 12% from $133M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Birchview Capital's Q3 2023 filing shows 13 increased, 4 reduced and 3 closed positions. The largest sale was Soleno Therapeutics, an estimated $1.05M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 96% a quarter earlier, followed by Energy and Consumer Staples.

  • Birchview Capital added most to Axogen in Q3 2023, an estimated $921K increase.
  • Birchview Capital's biggest Q3 2023 reduction was United Therapeutics, cutting an estimated $921K.
  • Birchview Capital fully exited Soleno Therapeutics in Q3 2023, selling an estimated $1.05M.
  • Birchview Capital's ten largest holdings make up 75% of its $118M portfolio in Q3 2023.
  • Birchview Capital opened 0 new positions and closed 3 in Q3 2023.
  • Birchview Capital's portfolio value fell 12% quarter-over-quarter to $118M.

Based on Birchview Capital's 13F filing for Q3 2023, filed 14 Nov 2023.